Published trade mark details for 2585663

This information was published on 2025-09-11T02:10:09 for IP Right Filed Published.

Field	Value
(210)	2585663 (IR 1875622)
(220)	06 Nov 2024
(300)	US, 07 May 2024, 98537479
(500)	The mark consists of a stylized Ampersand symbol to the left of the words "Ampersand" and "biomedicines" with the word "Ampersand" appearing above the word "biomedicines".
(511) (510)	Class 1 Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics. Class 5 Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical preparations, namely, addressable and programmable protein-based therapeutics, for treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders. Class 42 Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services.
(540)
(550)	Figurative
(730)	Ampersand Biomedicines, Inc.

 

Find out more about publications on the About page.